Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.
Phase 3 DESTINY-Breast05 compared adjuvant trastuzumab deruxtecan (T‑DXd, 5.4 mg/kg) with trastuzumab emtansine (T‑D...
What practicing pathologists and oncologists should know about the new computational pathology-based companion diagnostic tools.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This Perspective article reviews how AI-based computational pathology tools are becoming true companion diagnostics rath...
Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026).
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This systematic review traces nearly three decades of development of EGFR-targeted therapy in NSCLC, focusing on how suc...
Sunvozertinib A Next-Generation EGFR Exon 20 Insertion Inhibitor Transforming NSCLC Therapy.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This publication reviews the emerging role of sunvozertinib (DZD9008), a next‑generation EGFR tyrosine kinase inhibito...
Optimizing Nutritional Support in Advanced Non-Small Cell Lung Cancer: Evidence and Controversies in Oral, Enteral, and Parenteral Approaches.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This publication reviews malnutrition and cachexia in advanced lung cancer, emphasizing their high prevalence and impact...
Innovative approaches for lung cancer screening and interception.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This review article addresses why lung cancer remains the leading cause of cancer death and focuses on improving early d...